Exact Mass: 358.24675940000003
Exact Mass Matches: 358.24675940000003
Found 500 metabolites which its exact mass value is equals to given mass value 358.24675940000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cannabidiolate
A dihydroxybenzoic acid that is olivetolic acid in which the hydrogen at position 3 is substituted by a 3-p-mentha-1,8-dien-3-yl (limonene) group.
Pregnenolone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
11beta-Hydroxy-6alpha,11-dimethylprogesterone
D-Homotestosterone propionate
Sorgoleone 358
Sorgoleone 358 is found in cereals and cereal products. Sorgoleone 358 is a constituent of the etiolated seedlings of Sorghum bicolor (sorghum). Constituent of the etiolated seedlings of Sorghum bicolor (sorghum). Sorgoleone 358 is found in cereals and cereal products and sorghum.
Piperoic acid
Piperoic acid is found in herbs and spices. Piperoic acid is a constituent of the leaves of Piper auritum (Veracruz pepper). Constituent of the leaves of Piper auritum (Veracruz pepper). Piperoic acid is found in herbs and spices.
11,12-Dimethoxy-8,11,13-abietatrien-20,7-olide
11,12-Dimethoxy-8,11,13-abietatrien-20,7-olide is found in beverages. 11,12-Dimethoxy-8,11,13-abietatrien-20,7-olide is a constituent of Salvia columbariae (California chia)
Kinetensin 1-3
Kinetensin 1-3 is a fraction of kinetensin with only the Ile-Ala-Arg peptide chain. Kinetensin is a nonapeptide, originally isolated from pepsin-treated plasma that shares some sequence homology with the C-terminal end of neurotensin, serum albumin, and angiotensin. It is a potent histamine releaser in rodents and may serve as an inflammatory mediator. Kinetensin 1-3 is a fraction of Kinetensin with only Ile-Ala-Arg peptide chain.
13,14-Dihydro PGF-1a
13,14-Dihydro PGF-1alpha is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207) [HMDB] 13,14-Dihydro PGF-1alpha is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207).
24,25,26,27-Tetranor-23-oxo-hydroxyvitamin D3
This compound belongs to the family of Steroids and Steroid Derivatives. These are compounds based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred.
3,3'-Di-tert-butyl-5,5'-dimethoxybiphenyl-2,2'-diol
9-Carboxy-thc
Cannabidiolic acid
Canrenoic acid
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
Ferutinin
Ferutinin, a natural terpenoid compound, is an estrogen receptor ERα agonist and estrogen ERβ-receptor agonist/antagonist with IC50s of 33.1 nM and 180.5 nM, respectively. Ferutinin acts as an electrogenic Ca2+-ionophore that increases calcium permeability of lipid bilayer membranes, mitochondria. Ferutinin possesses estrogenic, antitumor, antibacterial and antiinflammatory activities[1][2].
Pracinostat
C20H30N4O2 (358.23686399999997)
Testosterone isobutyrate
16,17,18,20-Tetrahydroxy-10,11,14,15-tetrahydronerylgeraniol
Cannabichromenic acid
A chromenol that is 2H-chromene substituted by methyl, 2-methylpent-2-en-5-yl, hydroxy, carboxy and pentyl groups at positions 2,2,5,6 and 7, respectively.
Ferutinin
Ferutinin, a natural terpenoid compound, is an estrogen receptor ERα agonist and estrogen ERβ-receptor agonist/antagonist with IC50s of 33.1 nM and 180.5 nM, respectively. Ferutinin acts as an electrogenic Ca2+-ionophore that increases calcium permeability of lipid bilayer membranes, mitochondria. Ferutinin possesses estrogenic, antitumor, antibacterial and antiinflammatory activities[1][2].
4-hydroxy-2,5,5,9-tetramethylcycloundeca-2,9-dienyl 4-hydroxybenzoate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.449 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.453 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.451
Myrsinoic acid B
A member of the class of 1-benzofurans that is 2,3-dihydro-1-benzofuran substituted by a carboxy group at position 5, a 1,5-dimethyl-1-hydroxy-4-hexenyl group at position 2 and a prenyl group at position 7. Isolated from Myrsine seguinii, it exhibits anti-inflammatory activity.
4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid
ent-8,9-seco-7alpha-acetoxykaura-8(14),16-dien-9,15-dione|ent-8,9-Seco-7??-acetoxykaura-8(14),16-dien-9,15-dione
5-Methoxy-2-hydroxy-3-(1,2,4a-trimethyl-5-methylenedecalin-1-ylmethyl)-1,4-benzoquinone
9-(3,4-dihydro-7-hydroxy-2,5-dimethyl-2h-benzopyran-2-yl)-2,6-dimethyl-2,6-nonadienoic acid
12-oxoisospongia-13,15-dien-20-yl acetate|20-acetoxymarginatone
(3alpha,14beta)-14,16-epoxy-3,18-[(1-methylethane-1,1,diyl)dioxy]-ent-abieta-7,15(17)-diene-14,16-diol
(3S,4aS,10aS)-1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-9-oxophenanthren-3-yl acetate|2alpha-acetoxysugiol
2-(4-Methoxy-3-methyl-6-isopropylphenoxy)-4-methoxy-3-methyl-6-isopropylphenol
1-[7,8-dihydro-7-hydroxy-7-methyl-8-oxo-3-(1E)-1-propenyl-6H-2-benzopyran]undecan-2-one|rubropunctin
12-acetylroyleanone|12-O-Acetoxy-royleanon|7-acetyl-royleanone|Royleanone Acetat
(-)-Ochropposinine|10,11-dimethoxy-corynan-17-ol|ochroposinine|Ochropposinin|ochropposinine
3-acetoxyhelioscopinolide B|3beta-Acetoxy-Helioscopinolide B
(-)-(1betaH,7E)-6-beta-acetoxyverticilla-4(18),7,11-triene-10,12-gamma-lactone|(5R,10S,11E,13aR)-2,4,5,6,7,8,9,10,13,13a-decahydro-4,4,12-trimethyl-8-methylidene-2-oxo-3,5-ethanocyclododeca[b]furan-10-yl acetate|cespihypotin Y
(+)-hyatellaquinone|3-[[(1R,4aR,8aR)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]methyl]-2-hydroxy-5-methoxy-2,5-cyclohexadiene-1,4-dione|3-{[(1R,4aR,5R,8aR)-decahydro-5,5,8a-trimethyl-2-methylenenaphthalen-1-yl]methyl}-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione|hyatellaquinone
19-acetoxy-15,16-epoxy-8(17),13(16),14-ent-labdatrien-20-al
16,17,15,20-tetrahydrosecodin-17-ol|Tetrahydrosecodin-17-ol|Tetrahydrosecodinol
2,3-epoxy-jaeschkeanadiol benzoate|epoxybenz|epoxyferutinol benzoate|epoxyjaeschkeanadiol benzoate
3,17-dimethyl-18,19-dinor-17alpha-cholesta-1,3,5,7,9,11,13-heptaene
(2S,3S)-6-carboxy-2,3-dihydro-3-hydroxy-2-methyl-2-(4-methylpenta-3-enyl)-8-(3-methyl-2-butenyl)chroman|myrsinoic acid C
5-O-acetyl-13-deacetoxy-guanacastepene A|heptemerone G
2-[2-(5-hydroxy-2,7-dimethyl-2H-chromen-2-yl)-ethyl]-3,3-dimethyl-cyclohexanecarboxylic acid|Siccanochromen-G|Siccanochromene-G
12-formyl-11-hydroxy-8,11,13-abietatrien-2-oic acid methylester
(1S*,2S*,11S*,3E,7E,12Z)-11-acetoxycembra-3,7,12(13),15(17)-tetraen-16,2-olide|crassocolide P
4beta,9alpha-dihydroxy-6alpha-benzoyl-dauc-7-ene|lancerotriol benzoate
(2R,13Z)-2-acetoxy-10-oxo-4,10-secospata-2,13(15),17-trien-12-al
4-hydroxy-3-((E)-4-hydroxy-3,7-dimethyl-octa-2,6-dienyl)-5-(3-methyl-but-2-enyl)-benzoic acid
5-Acetyl-2,3-dihydrobenzofuran 2-(2-methyleneethanol)nonanoate
4beta,8beta-dihydroxy-6alpha-benzoyldauc-9-ene|feruhermonin B
(3beta,5beta,14beta)-14,21-epoxy-24-norcholan-20,22-diene-3,5-diol
(3S*,3aR*,5aR*,6S*,8aR*,11bS*,11cS*)-2,3,3a,5,5a,6,7,8,8a,9,10,11c-dodecahydro-5a-(hydroxymethyl)-3-methyl-1,6-methano-1H-azuleno[5,4-g]indole-11b(4H)-propanamide|macropodumine I
2-alpha-acetyloxy-5-alpha-pregn-17(20)-(cis)-en-16-one
5-hydroxy-2,6,8-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2H-1-benzopyran-4,7(3H,8H)-dione
12beta-Hydroxy-16alpha-methoxy-pregna-4,6-dien-3,20-dion
Ac-(5alpha,10alpha,11beta,13alpha)-5,10-Epoxy-11-hydroxy-1,15-rosadien-3-one
Di-Me ester-8,11,13-Cleistanthatriene-17,19-dioic acid
(5R,13Z)-5-acetoxy-10-oxo-4,10-secospata-2,13(15),17-trien-12-al|(5R,13Z)-5.acetoxy-10-oxo-4,10-secospata-2,13(15),17-trien-12-al
2-hydroxy-4-methoxy-3-{[(2S,4aS,8aS)-octahydro-2,5,5,8a-tetramethylnaphthalen-1(2H)-ylidene]methyl}cyclohexa-2,5-diene-1,4-dione|Spongiachinon|Spongiaquinone
agallochin C|ent-15-chloro-labd-8(9)-en-3alpha,13,14-triol
C20H35ClO3 (358.22745900000007)
3-[2-butyl-1-[2-(diethylamino)ethyl]-5-benzimidazolyl]-N-hydroxy-2-propenamide
C20H30N4O2 (358.23686399999997)
Ala Ala Val Val
Ala Gly Ile Val
Ala Gly Leu Val
Ala Gly Val Ile
Ala Gly Val Leu
Ala Ile Gly Val
Ala Ile Val Gly
Ala Leu Gly Val
Ala Leu Val Gly
Ala Val Ala Val
Ala Val Gly Ile
Ala Val Gly Leu
Ala Val Ile Gly
Ala Val Leu Gly
Ala Val Val Ala
Gly Ala Ile Val
Gly Ala Leu Val
Gly Ala Val Ile
Gly Ala Val Leu
Gly Gly Ile Ile
Gly Gly Ile Leu
Gly Gly Leu Ile
Gly Gly Leu Leu
Gly Ile Ala Val
Gly Ile Gly Ile
Gly Ile Gly Leu
Gly Ile Ile Gly
Gly Ile Leu Gly
Gly Ile Val Ala
Gly Leu Ala Val
Gly Leu Gly Ile
Gly Leu Gly Leu
Gly Leu Ile Gly
Gly Leu Leu Gly
Gly Leu Val Ala
Gly Val Ala Ile
Gly Val Ala Leu
Gly Val Ile Ala
Gly Val Leu Ala
Ile Ala Gly Val
Ile Ala Val Gly
Ile Gly Ala Val
Ile Gly Gly Ile
Ile Gly Gly Leu
Ile Gly Ile Gly
Ile Gly Leu Gly
Ile Gly Val Ala
Ile Ile Gly Gly
Ile Leu Gly Gly
Ile Val Ala Gly
Ile Val Gly Ala
Leu Ala Gly Val
Leu Ala Val Gly
Leu Gly Ala Val
Leu Gly Gly Ile
Leu Gly Gly Leu
Leu Gly Ile Gly
Leu Gly Leu Gly
Leu Gly Val Ala
Leu Ile Gly Gly
Leu Leu Gly Gly
Leu Val Ala Gly
Leu Val Gly Ala
Val Ala Ala Val
Val Ala Gly Ile
Val Ala Gly Leu
Val Ala Ile Gly
Val Ala Leu Gly
Val Ala Val Ala
Val Gly Ala Ile
Val Gly Ala Leu
Val Gly Ile Ala
Val Gly Leu Ala
Val Ile Ala Gly
Val Ile Gly Ala
Val Leu Ala Gly
Val Leu Gly Ala
Val Val Ala Ala
PGF2alpha-d4
13,14-DIHYDRO PROSTAGLANDIN F1ALPHA
tetranor-23-oxo-1alpha(OH)D3
ascr#21
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,12R)-12-hydroxytridec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#21
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-13-hydroxytridec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
Amidonal
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators
Butanedioic acid,2-hydroxy-, 1,4-bis(2-ethylhexyl) ester
1-(tert-butyldimethylsilyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine
C19H31BN2O2Si (358.22477359999993)
sodium 3,9-diethyltridecan-6-yl sulphate
C17H35NaO4S (358.2153630000001)
1-(1-ADAMANTYL)-3-(2,4,6-TRIMETHYLPHENYL)-4,5-DIHYDROIMIDAZOLIUM CHLORIDE
tert-butyl 4-(3-ethyl-3-methyl-2-oxoindol-1-yl)piperidine-1-carboxylate
(1S,2S,3S,4R)-3-[(1S)-1-Amino-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-cyclopentanecarboxylic acid methyl ester
C18H34N2O5 (358.24675940000003)
2,2’-(2,5-Dimethyl-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
Thiourea, N-cyclopentyl-N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-propyl- (9CI)
Bis-(2-Methyl-benzyl)-piperidin-2-ylMethyl-aMine hydrochloride
5-ethyl-2-methylidenenonanoic acid,methyl propanoate,prop-2-enoic acid
3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-benzoyl-, 1,1-dimethylethyl ester
(2E,12R)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridec-2-enoic acid
16-Butyl-3-methoxy-estra-1,3,5(10)-triene-16beta,17beta-diol
Silane, [[3,7-dimethyl-9-(2,6,6-trimethyl-2-cyclohexen-1-ylidene)-3,5,7-nonatrienyl]oxy]trimethyl-
C23H38OSi (358.26917779999997)
17beta-Hydroxy-7alpha-methylandrost-4-en-3-one propionate
Pracinostat
C20H30N4O2 (358.23686399999997)
C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
(2E)-13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridec-2-enoic acid
[3-carboxy-2-[(Z)-3-hydroxydodec-9-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-10-carboxydec-6-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-2-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-8-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-3-hydroxydodec-4-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-3-hydroxydodec-6-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-3-hydroxydodec-8-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-5-hydroxydodec-7-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-7-hydroxydodec-9-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-8-hydroxydodec-10-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-Carboxy-2-(3-oxododecanoyloxy)propyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
Leu-Leu-Asn
A tripeptide composed of two L-leucine units joined to L-asparagine by a peptide linkage.
((2,2-Dimethyl-3-vinyl-2H-chromen-7-yl)oxy)triisopropylsilane
Ethyl {(1s,4s,5s)-4-[(isonicotinoylamino)methyl]-5-isopropyl-2-methyl-2-cyclohexen-1-yl}acetate
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
6,7-dimethoxy-N,N-dipropyl-2-(1-pyrrolidinyl)-4-quinazolinamine
C20H30N4O2 (358.23686399999997)
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
(1-Hydroxy-3-propanoyloxypropan-2-yl) tetradecanoate
(1e,3as,3br,5as,7r,9as,9bs,11as)-1-ethylidene-9a,11a-dimethyl-2-oxo-dodecahydro-3h-cyclopenta[a]phenanthren-7-yl acetate
(1r,5r,6r)-4-ethyl-5-hydroxy-1-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-2-one
(2s,5r,6r,10r,13s,14r)-13-acetyl-2,5,10,14-tetramethyltetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-1(9)-ene-5-carboxylic acid
(1r,3as,3bs,4s,7r,9ar,9bs,11ar)-1-ethenyl-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
3-hydroxypregn-17(20)-en-16-one; (3α,5α,17(20)e)-form,ac
{"Ingredient_id": "HBIN008743","Ingredient_name": "3-hydroxypregn-17(20)-en-16-one; (3\u03b1,5\u03b1,17(20)e)-form,ac","Alias": "NA","Ingredient_formula": "C23H34O3","Ingredient_Smile": "NA","Ingredient_weight": "358.51","OB_score": "NA","CAS_id": "166901-88-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8072","PubChem_id": "NA","DrugBank_id": "NA"}
agallochin c
C20H35ClO3 (358.22745900000007)
{"Ingredient_id": "HBIN014804","Ingredient_name": "agallochin c","Alias": "NA","Ingredient_formula": "C20H35ClO3","Ingredient_Smile": "CC1=C(C2(CCC(C(C2CC1)(C)C)O)C)CCC(C)(C(CCl)O)O","Ingredient_weight": "358.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "686","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "15543015","DrugBank_id": "NA"}
(4s,6e,8e,10s,11e,14e)-4,6,8,10,12,14-hexamethylheptadeca-6,8,11,14-tetraene-3,5,13-trione
(1r,4r,4ar,8as)-4-[(2s,5r)-5-{2-[(hydroxymethylidene)amino]propan-2-yl}-2-methyloxolan-2-yl]-1-isocyano-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalene
1-ethylidene-9a,11a-dimethyl-2-oxo-dodecahydro-3h-cyclopenta[a]phenanthren-7-yl acetate
(1r,3as,3bs,5as,9as,9bs,10r,11ar)-1-ethenyl-9a,11a-dimethyl-7-oxo-tetradecahydrocyclopenta[a]phenanthren-10-yl acetate
(2r,3e,5s)-2-[(1r,11ar)-11a-methyl-1h,2h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5,6-dimethylhept-3-ene
(1r,3as,3br,4s,5as,9as,9bs,11ar)-1-ethenyl-9a,11a-dimethyl-7-oxo-tetradecahydrocyclopenta[a]phenanthren-4-yl acetate
(1s,10s,12s,17r,18r)-4-ethenyl-8,8,13,13,17-pentamethyl-7,9-dioxatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadec-4-en-3-one
2,4-dimethoxy-6-[3-methyl-5-(1,2,6-trimethylcyclohex-2-en-1-yl)pent-2-en-1-yl]phenol
(4s,10s)-4,6,8,10,12,14-hexamethylheptadeca-6,8,11,14-tetraene-3,5,13-trione
1-chloro-5-(6-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpentane-2,3-diol
C20H35ClO3 (358.22745900000007)
1,14,17,17-tetramethyl-6-methylidene-8,16,18-trioxapentacyclo[11.8.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]henicos-10-ene
(15e)-16-(2h-1,3-benzodioxol-5-yl)hexadec-15-en-2-one
(1r,4s,7s,9ar,11ar)-1-ethenyl-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
8-(methoxymethyl)-4,4,6a,11b-tetramethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluorene-7,10-diol
1-ethenyl-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
(4as,6as,11ar,11bs)-7-(methoxymethyl)-4,4,6a,11b-tetramethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluorene-9,10-diol
(1s,2r,5s,7s,10r,11s,14r,15r)-16-ethenyl-10,14-dimethyl-18-oxapentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icos-16-ene-5,7-diol
6-[2-(but-2-en-2-yl)-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-3-yl]-3-methylhexa-3,5-dien-2-one
1-ethenyl-9a,11a-dimethyl-7-oxo-tetradecahydrocyclopenta[a]phenanthren-10-yl acetate
(1r,3as,3bs,4s,7s,9ar,9bs,11ar)-1-ethenyl-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
n-[(1r,4r,4ar,8as)-4-[(2s,5r)-5-(2-isocyanopropan-2-yl)-2-methyloxolan-2-yl]-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalen-1-yl]carboximidic acid
2-[(2r,3r,12bs)-3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]ethanol
4-ethenyl-8,8,13,13,17-pentamethyl-7,9-dioxatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadec-4-en-3-one
(2s,3s)-5-[(4as,6s,8ar)-6-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-1-chloro-3-methylpentane-2,3-diol
C20H35ClO3 (358.22745900000007)
(3e,5e)-6-[(1ar,2r,3s,3as,6s,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-3-yl]-3-methylhexa-3,5-dien-2-one
2,4-dimethoxy-6-[(2e)-3-methyl-5-[(1r,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]pent-2-en-1-yl]phenol
(3e)-16-(2h-1,3-benzodioxol-5-yl)hexadec-3-en-2-one
(3s)-5-[(4as,6s,8ar)-6-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-1-chloro-3-methylpentane-2,3-diol
C20H35ClO3 (358.22745900000007)